FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approves a supplemental application for LANOXIN (digoxin) from Advanz Pharma (US) Corp., under the supplemental NDA framework.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Heart Failure

Drugs mentioned

• LANOXIN (Digoxin)

Snippet

SUPPL AP for LANOXIN (DIGOXIN)